Literature DB >> 7720412

Analysis of centromeric activity in Robertsonian translocations: implications for a functional acrocentric hierarchy.

B A Sullivan1, D J Wolff, S Schwartz.   

Abstract

Approximately 90% of human Robertsonian translocations occur between nonhomologous acrocentric chromosomes, producing dicentric elements which are stable in meiosis and mitosis, implying that one centromere is functionally inactivated or suppressed. To determine if this suppression is random, centromeric activity in 48 human dicentric Robertsonian translocations was assigned by assessment of the primary constrictions using dual color fluorescence in situ hybridization (FISH). Preferential activity/constriction of one centromere was observed in all except three different rearrangements. The activity is meiotically stable since intrafamilial consistency of a preferentially active centromere existed in members of six families. These results support evidence for nonrandom centromeric activity in humans and, more importantly, suggest a functional hierarchy in Robertsonian translocations with the chromosome 14 centromere most often active and the chromosome 15 centromere least often active.

Entities:  

Mesh:

Year:  1994        PMID: 7720412     DOI: 10.1007/bf00337384

Source DB:  PubMed          Journal:  Chromosoma        ISSN: 0009-5915            Impact factor:   4.316


  49 in total

Review 1.  The possibility of latent centromeres and a proposed nomenclature system for total chromosome and whole arm translocations.

Authors:  T C Hsu; S Pathak; T R Chen
Journal:  Cytogenet Cell Genet       Date:  1975

2.  Structure and inheritance of some heterozygous Robertsonian translocation in man.

Authors:  A Daniel; P R Lam-Po-Tang
Journal:  J Med Genet       Date:  1976-10       Impact factor: 6.318

Review 3.  Role of acrocentric cen-pter satellite DNA in Robertsonian translocation and chromosomal non-disjunction.

Authors:  K H Choo
Journal:  Mol Biol Med       Date:  1990-10

4.  A chromosome 14-specific human satellite III DNA subfamily that shows variable presence on different chromosomes 14.

Authors:  K H Choo; E Earle; B Vissel; P Kalitsis
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

5.  A Transmissible Dicentric Chromosome.

Authors:  E R Sears; A Câmara
Journal:  Genetics       Date:  1952-03       Impact factor: 4.562

6.  Long-range analyses of the centromeric regions of human chromosomes 13, 14 and 21: identification of a narrow domain containing two key centromeric DNA elements.

Authors:  H E Trowell; A Nagy; B Vissel; K H Choo
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

7.  Cytogenetic studies of a patient with mosaicism of isochromosome 13q and a dicentric (Y;13) translocation showing differential centromeric activity.

Authors:  P S Ing; S D Smith
Journal:  Clin Genet       Date:  1983-09       Impact factor: 4.438

8.  Dicentric chromosome 13 and centromere inactivation.

Authors:  S Schwartz; C G Palmer; D D Weaver; J Priest
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  Telomeric signals in robertsonian fusion and fission chromosomes: implications for the origin of pseudoaneuploidy.

Authors:  I Schubert; G Schriever-Schwemmer; T Werner; I D Adler
Journal:  Cytogenet Cell Genet       Date:  1992

10.  Integration of human alpha-satellite DNA into simian chromosomes: centromere protein binding and disruption of normal chromosome segregation.

Authors:  T Haaf; P E Warburton; H F Willard
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

View more
  14 in total

1.  Time course study of the chromosome-type breakage-fusion-bridge cycle in maize.

Authors:  Y Z Zheng; R R Roseman; W R Carlson
Journal:  Genetics       Date:  1999-11       Impact factor: 4.562

2.  Influences of chromosome size, gene density and nuclear position on the frequency of constitutional translocations in the human population.

Authors:  Wendy A Bickmore; Peter Teague
Journal:  Chromosome Res       Date:  2002       Impact factor: 5.239

3.  Evidence for structural heterogeneity from molecular cytogenetic analysis of dicentric Robertsonian translocations.

Authors:  B A Sullivan; L S Jenkins; E M Karson; J Leana-Cox; S Schwartz
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

4.  α satellite DNA variation and function of the human centromere.

Authors:  Lori L Sullivan; Kimberline Chew; Beth A Sullivan
Journal:  Nucleus       Date:  2017-04-13       Impact factor: 4.197

Review 5.  Dicentric chromosomes: unique models to study centromere function and inactivation.

Authors:  Kaitlin M Stimpson; Justyne E Matheny; Beth A Sullivan
Journal:  Chromosome Res       Date:  2012-07       Impact factor: 5.239

6.  Molecular definition of breakpoints associated with human Xq isochromosomes: implications for mechanisms of formation.

Authors:  D J Wolff; A P Miller; D L Van Dyke; S Schwartz; H F Willard
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

7.  Centromere Destiny in Dicentric Chromosomes: New Insights from the Evolution of Human Chromosome 2 Ancestral Centromeric Region.

Authors:  Giorgia Chiatante; Giuliana Giannuzzi; Francesco Maria Calabrese; Evan E Eichler; Mario Ventura
Journal:  Mol Biol Evol       Date:  2017-07-01       Impact factor: 16.240

8.  Engineered human dicentric chromosomes show centromere plasticity.

Authors:  Anne W Higgins; Karen M Gustashaw; Huntington F Willard
Journal:  Chromosome Res       Date:  2005-12-08       Impact factor: 5.239

9.  Centromere inactivation on a neo-Y fusion chromosome in threespine stickleback fish.

Authors:  Jennifer N Cech; Catherine L Peichel
Journal:  Chromosome Res       Date:  2016-08-23       Impact factor: 5.239

10.  Telomere disruption results in non-random formation of de novo dicentric chromosomes involving acrocentric human chromosomes.

Authors:  Kaitlin M Stimpson; Ihn Young Song; Anna Jauch; Heidi Holtgreve-Grez; Karen E Hayden; Joanna M Bridger; Beth A Sullivan
Journal:  PLoS Genet       Date:  2010-08-12       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.